Cargando…
Genetic polymorphism of drug refractory epilepsy
Autores principales: | Kesavan, R., Kukreti, Ritushree, Adithan, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193704/ https://www.ncbi.nlm.nih.gov/pubmed/21985806 |
Ejemplares similares
-
NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity
por: Adithan, C., et al.
Publicado: (2016) -
Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics
por: Grover, Sandeep, et al.
Publicado: (2011) -
Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017) -
Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019) -
Structural Switch from Hairpin to Duplex/Antiparallel
G-Quadruplex at Single-Nucleotide Polymorphism (SNP) Site of
Human Apolipoprotein E (APOE) Gene Coding Region
por: Chaudhary, Swati, et al.
Publicado: (2018)